Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), headquartered in Massachusetts, is a global biopharmaceutical enterprise ...

Additionally, the FDA has granted a Priority Review for Revuforj’s supplemental New Drug Application (sNDA) in relapsed or ...

Spectral Ai, Inc. Class A ( ($MDAI) ) has released its Q2 earnings. Here is a breakdown of the information Spectral Ai, Inc. Class A presented to ...

Cardiology is undergoing a year of rapid change, driven by innovations that are expanding diagnostic capabilities, advancing treatment options and personalizing care. From artificial intelligence and ...

Artificial intelligence programs can help doctors and nurses predict hours earlier which ER patients will likely require ...

The use of artificial intelligence for batch monitoring and digital twin development are redefining process control — ...

Martin, a practicing vascular surgeon, said he'll continue working with the portable ultrasound developer Butterfly Network as CMO emeritus ...

Recent news reports highlight uncertainty about pharmaceutical tariffs, an error-prone AI tool in use at the FDA, and scientific research funding in jeopardy.

Explore AI governance in MedTech. Learn about regulatory risks, compliance & strategy in our expert-led webinar. Stay ahead in health tech innovation.

An interview with Philip Vanek, chief commercialization officer of the International Society for Cell & Gene Therapy (ISCT), ...

Californian biotech startup Geltor has secured fresh funding to expand its biodesigned polypeptides, including ...

Precision Neuroscience says it may have a better way to restore independence to those with paralysis — by targeting the brain ...